National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
about
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseasesTamoxifen Resistance: Emerging Molecular TargetsGamma-enolase: a well-known tumour marker, with a less-known role in cancerA critical review of the analytical approaches for circulating tumor biomarker kinetics during treatmentCurrent approaches and challenges for monitoring treatment response in colon and rectal cancerScrotal swelling in the neonate.Exosomes genetic cargo in lung cancer: a truly Pandora's boxBlood peptidome-degradome profile of breast cancerProteomic profiling of a mouse model for ovarian granulosa cell tumor identifies VCP as a highly sensitive serum tumor marker in several human cancers.Biomarker discovery and development in pediatric critical care medicine.Assessing the clinical utility of cancer genomic and proteomic data across tumor types.Imaging and 'omic' methods for the molecular diagnosis of cancer.Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients.The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.Pathogenesis of ovarian cancer: clues from selected overexpressed genes.CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patientsMUC16 (CA125): tumor biomarker to cancer therapy, a work in progressInternational scientific communications in the field of colorectal tumour markersRevisiting the technical validation of tumour biomarker assays: how to open a Pandora's box.Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.Chitotriosidase, a marker of innate immunity, is elevated in patients with primary breast cancer.Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation TherapyTissue polypeptide antigen & interleukin-6: Are their serum levels a predictor for response to chemotherapy in breast cancer?Cancer biomarkers: can we turn recent failures into success?The evolving role of mass spectrometry in cancer biomarker discoveryAutoantibodies to tumor-associated antigens in breast carcinoma.Monitoring response to therapy in patients with cancer: is circulating DNA the answer?Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateSerum microRNA-155 as a potential biomarker to track disease in breast cancerPreclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertilityAutoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma.Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis.Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese womenDNA methylation ratio variability may impede clinical application of cancer diagnostic markers.Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy.Effect of cinnamon on gastric emptying, arterial stiffness, postprandial lipemia, glycemia, and appetite responses to high-fat breakfastAdvances in urinary protein biomarkers for urogenital and non-urogenital pathologies.Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.
P2860
Q24634978-E49B464B-F617-402D-BFE6-3A1AD120253BQ26739969-AAE30748-0EA9-44D1-850F-DE713475309CQ26781703-215BD27E-1813-4B27-BE61-878B2CAEA0A5Q26862558-9DF47CE8-312C-4EDD-84B9-C9DEE33F3FC8Q27010257-DF048111-31B1-4C5B-ABA6-F048F02C2C94Q27028102-DCF0962E-00C5-4DBD-BBC1-F702E470E3CFQ28079149-F25D75FE-75CB-48D0-A553-2F55C974E6C6Q28475815-420C065D-1902-47EB-87B4-622780CB7216Q30425624-42D42778-9EDF-49AF-B679-F6EE4EC1F8CCQ30428168-961E22BB-F5D9-48BB-ACA6-80101F9660C5Q30487077-8F5BDF7E-CCED-4CE0-A8C2-002E9E69A1F6Q33577268-45ACFBBF-AC96-415E-AE82-5A1A1C67CC7CQ33612332-3462B68B-BD52-477C-915A-56EF1DA76CEBQ33618617-E3D3DF2D-C0C3-4D98-8D5B-6787905D5F63Q33651139-1C778D78-2A2A-4395-B3B7-D4E70929DF4BQ33683996-38EDA8FE-A63D-4306-9EA9-DF97CE90EE86Q33713506-780206C6-FF20-4D85-94D2-CE0A231AAF78Q33721159-0D7D8CB8-4788-4EC7-98D9-21F97A664ED2Q33876854-3D785E1B-9462-448E-A71B-FFEFAABC32E1Q33907528-B2D706C8-7D26-4983-A63C-471C2BB8BF92Q33919829-E70733BB-AF30-4D8A-AF92-4CD07D90829DQ34118056-99B82FD6-D2D8-4610-AECC-A195787791CDQ34176287-7BD0178E-82A4-4FC5-8CFA-B72915AE1837Q34176379-425BCF28-6328-4497-9F5F-3DD6E65C456CQ34215422-FB40B175-E478-430A-8C5F-1FC7C271B2D7Q34339160-D8493EF4-754A-4B27-8B2B-D5042C897D82Q34358015-869BAB83-2ABB-4DD5-B14F-1B3BFD9CE924Q34434875-835E6F3D-8FE5-486D-9AF7-45C70EA36DDAQ34441837-DE03B5A0-1288-446F-ACFC-7F1A16EE07B4Q34447755-23006766-4186-4B04-BEA5-EBAE549A97E0Q34553859-CF19BA67-D750-47F2-8A05-AFC4E7A159C8Q34665049-9430C3BE-7A19-4E78-A5CE-292D1442A394Q34876546-F11C36A1-9496-43DE-9560-FBADAF981189Q35112630-6F313E6F-5DFA-45ED-BC5A-22FE99440C54Q35126762-CDCB563C-7B5D-42D7-B648-93441D0B0D15Q35191841-2EE945B4-363E-485D-B3B3-94248E3D07EAQ35224176-6B21F938-21DB-4B0D-A7B8-45FD796A814AQ35232743-A529196E-85AD-4569-8728-F37C2197E9D4Q35460015-5F766044-4FCC-4EDE-9EF5-5CF049D756B9Q35519793-E3209DF3-7E1B-4DCD-8203-EED9FD57EBAA
P2860
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
National Academy of Clinical B ...... , breast, and ovarian cancers.
@ast
National Academy of Clinical B ...... , breast, and ovarian cancers.
@en
National Academy of Clinical B ...... , breast, and ovarian cancers.
@nl
type
label
National Academy of Clinical B ...... , breast, and ovarian cancers.
@ast
National Academy of Clinical B ...... , breast, and ovarian cancers.
@en
National Academy of Clinical B ...... , breast, and ovarian cancers.
@nl
prefLabel
National Academy of Clinical B ...... , breast, and ovarian cancers.
@ast
National Academy of Clinical B ...... , breast, and ovarian cancers.
@en
National Academy of Clinical B ...... , breast, and ovarian cancers.
@nl
P2093
P50
P1433
P1476
National Academy of Clinical B ...... , breast, and ovarian cancers.
@en
P2093
Axel Semjonow
Barry Dowell
Barry R Hoffman
Caj Haglund
Carsten Stephan
Catharine M Sturgeon
Daniel F Hayes
Daniel W Chan
George G Klee
György Sölétormos
P304
P356
10.1373/CLINCHEM.2008.105601
P407
P50
P577
2008-12-01T00:00:00Z